User talk:71.112.31.9
From Wikipedia, the free encyclopedia
[edit] Statin
I have again removed your addition of the ENHANCE trial, as it reflects mainly on the inability of ezetimibe to confer benefit in addition to simvastatin in a study using a validated surrogate endpoint.
I have addressed your concerns on Talk:Statin. Please respond to these messages first and try to achieve consensus before making further changes to statin. JFW | T@lk 07:10, 25 April 2008 (UTC)
 | This is the discussion page for an anonymous user, identified by the user's numerical IP address. Some IP addresses change periodically, and may be shared by several users. If you are an anonymous user, you may create an account or log in to avoid future confusion with other anonymous users. Registering also hides your IP address. [WHOIS • RDNS • RBLs • Traceroute • Geolocate • Tor check • Rangeblock finder] · [RIRs: America · Europe · Africa · Asia-Pacific · Latin America/Caribbean] |
